NO20020999L - Mesoprogestiner (progesteronreseptormodulatorer) for behandling og forhindring av godartete hormonavhengigegynekologiske sykdommer - Google Patents

Mesoprogestiner (progesteronreseptormodulatorer) for behandling og forhindring av godartete hormonavhengigegynekologiske sykdommer

Info

Publication number
NO20020999L
NO20020999L NO20020999A NO20020999A NO20020999L NO 20020999 L NO20020999 L NO 20020999L NO 20020999 A NO20020999 A NO 20020999A NO 20020999 A NO20020999 A NO 20020999A NO 20020999 L NO20020999 L NO 20020999L
Authority
NO
Norway
Prior art keywords
mesoprogestins
prevention
treatment
receptor modulators
progesterone receptor
Prior art date
Application number
NO20020999A
Other languages
English (en)
Norwegian (no)
Other versions
NO20020999D0 (no
Inventor
Kristof Chwalisz
Walter Elger
Gerd Schubert
Original Assignee
Jenapharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jenapharm Gmbh filed Critical Jenapharm Gmbh
Publication of NO20020999D0 publication Critical patent/NO20020999D0/no
Publication of NO20020999L publication Critical patent/NO20020999L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32Antioestrogens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34Gestagens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Pyridine Compounds (AREA)
NO20020999A 1999-08-31 2002-02-28 Mesoprogestiner (progesteronreseptormodulatorer) for behandling og forhindring av godartete hormonavhengigegynekologiske sykdommer NO20020999L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38614199A 1999-08-31 1999-08-31
PCT/US2000/023770 WO2001015679A2 (en) 1999-08-31 2000-08-31 Mesoprogestins for the treatment and prevention of benign hormone dependent gynecological disorders

Publications (2)

Publication Number Publication Date
NO20020999D0 NO20020999D0 (no) 2002-02-28
NO20020999L true NO20020999L (no) 2002-03-14

Family

ID=23524338

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020999A NO20020999L (no) 1999-08-31 2002-02-28 Mesoprogestiner (progesteronreseptormodulatorer) for behandling og forhindring av godartete hormonavhengigegynekologiske sykdommer

Country Status (34)

Country Link
EP (1) EP1229906B1 (cs)
JP (1) JP2003535029A (cs)
KR (3) KR20080066095A (cs)
AR (1) AR025457A1 (cs)
AT (1) ATE375160T1 (cs)
AU (1) AU781840B2 (cs)
BG (1) BG65817B1 (cs)
BR (1) BR0014161A (cs)
CA (1) CA2382580C (cs)
CO (1) CO5200772A1 (cs)
CZ (1) CZ2002704A3 (cs)
DE (1) DE60036723T2 (cs)
DK (1) DK1229906T3 (cs)
EA (1) EA007854B1 (cs)
EE (1) EE05172B1 (cs)
ES (1) ES2295050T3 (cs)
HR (1) HRP20020267A2 (cs)
HU (1) HUP0202429A3 (cs)
IL (1) IL148416A0 (cs)
LT (1) LT5034B (cs)
LV (1) LV12941B (cs)
ME (1) MEP13808A (cs)
MX (1) MXPA02002191A (cs)
NO (1) NO20020999L (cs)
NZ (1) NZ517471A (cs)
PE (1) PE20010578A1 (cs)
PL (1) PL198790B1 (cs)
PT (1) PT1229906E (cs)
RO (1) RO122179B1 (cs)
RS (1) RS50283B (cs)
SI (1) SI20852B (cs)
SK (1) SK287192B6 (cs)
UA (1) UA78184C2 (cs)
WO (1) WO2001015679A2 (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10236405A1 (de) 2002-08-02 2004-02-19 Schering Ag Progesteronrezeptormodulatoren mit erhöhter antigonadotroper Aktivität für die weibliche Fertilitätskontrolle und Hormonersatztherapie
AU2003255355A1 (en) * 2002-08-02 2004-02-25 Schering Aktiengesellschaft Progesterone receptor modulators having an increased antigonadotropic activity for use in female fertility testing and hormone replacement therapy
US20040097591A1 (en) * 2002-11-18 2004-05-20 Kristof Chwalisz Use of selective progesterone receptor modulators for the treatment of androgen deficiency
DE102007011105A1 (de) 2007-03-02 2008-09-04 Bayer Schering Pharma Aktiengesellschaft Mineralcorticoid-Rezeptor-Antagonisten zur Behandlung von Endometriose
AU2010260885B2 (en) * 2009-06-17 2015-03-12 Keio University Prophylactic and/or therapeutic agent for dysmenorrhea
US8399432B2 (en) * 2009-10-27 2013-03-19 Lipogen Ltd. Compositions and methods of treatment for alleviating premenstrual syndrome symptoms
CA3152099A1 (en) * 2019-09-23 2021-04-01 Liang Liang Methods of treatments to prolong gestation and complications of menstruation or gestation

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3633244A1 (de) 1986-09-26 1988-03-31 Schering Ag Antigestagene zur hemmung der uterinen prostaglandinsynthese
DE4332283A1 (de) * 1993-09-20 1995-04-13 Jenapharm Gmbh Neue 11-Benzaldoximestradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE4332284C2 (de) 1993-09-20 1997-05-28 Jenapharm Gmbh 11-Benzaldoxim-17beta-methoxy-17alpha-methoxymethyl-estradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US5681817A (en) * 1994-02-04 1997-10-28 The Medical College Of Hampton Roads Treatment of ovarian estrogen dependent conditions
US5576310A (en) * 1994-09-20 1996-11-19 Jenapharm Gmbh 11-benzaldoxime-17β-methoxy-17α-methoxymethyl-estrasdiene derivatives, methods for their production and pharmaceuticals containing such compounds
ES2208699T3 (es) * 1994-12-22 2004-06-16 Ligand Pharmaceuticals Incorporated Compuestos y metodos moduladores de receptores de esteroides.
US5688810A (en) * 1994-12-22 1997-11-18 Ligand Pharmaceuticals Incorporated Steroid receptor modulator compounds and methods
HU226276B1 (en) 1995-02-02 2008-07-28 Schering Ag The use of progesterone antagonists for preparing medicaments for the treatment of dysfunctional uterine bleeding
DE19604231A1 (de) * 1996-01-29 1997-07-31 Schering Ag Pharmazeutisches Kombinationspräparat und seine Verwendung zur Behandlung von gynäkologischen Störungen
HU230492B1 (hu) * 1996-05-01 2016-08-29 The Government Of The United States Of America Új progesztációt gátló szerként használható 21-helyzetben szubsztituált progeszteron-származékok, ezeket tartalmazó gyógyszerkészítmények, alkalmazásuk
WO1998005679A2 (en) * 1996-08-05 1998-02-12 Duke University Mixed agonists of the progesterone receptor and assays therefor
DE19809845A1 (de) * 1998-03-03 1999-09-09 Jenapharm Gmbh S-substituierte 11beta-Benzaldoxim-estra-4,9-dien-kohlensäurethiolester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
AU2708700A (en) * 1999-01-14 2000-08-01 Bayer Corporation Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents
WO2000066590A2 (en) * 1999-05-04 2000-11-09 Ligand Pharmaceuticals, Inc. Tetracyclic progesterone receptor modulator compounds and methods

Also Published As

Publication number Publication date
LV12941B (en) 2003-06-20
AR025457A1 (es) 2002-11-27
DK1229906T3 (da) 2008-02-11
UA78184C2 (en) 2007-03-15
JP2003535029A (ja) 2003-11-25
EA007854B1 (ru) 2007-02-27
RS50283B (sr) 2009-09-08
MEP13808A (en) 2010-06-10
IL148416A0 (en) 2002-09-12
EP1229906B1 (en) 2007-10-10
HUP0202429A2 (en) 2002-10-28
DE60036723D1 (de) 2007-11-22
CA2382580C (en) 2009-05-19
ATE375160T1 (de) 2007-10-15
KR20070058023A (ko) 2007-06-07
KR100755109B1 (ko) 2007-09-04
BG65817B1 (bg) 2010-01-29
CZ2002704A3 (cs) 2003-02-12
CA2382580A1 (en) 2001-03-08
SK2992002A3 (en) 2002-07-02
PT1229906E (pt) 2008-01-18
LT2002031A (en) 2003-02-25
EP1229906A2 (en) 2002-08-14
AU6946600A (en) 2001-03-26
MXPA02002191A (es) 2002-09-30
NZ517471A (en) 2004-02-27
KR100864547B1 (ko) 2008-10-20
DE60036723T2 (de) 2008-07-17
YU14002A (sh) 2006-01-16
WO2001015679A2 (en) 2001-03-08
SI20852B (sl) 2009-06-30
PE20010578A1 (es) 2001-06-04
EE05172B1 (et) 2009-06-15
LT5034B (lt) 2003-07-25
KR20020027616A (ko) 2002-04-13
BG106442A (bg) 2002-09-30
PL353930A1 (en) 2003-12-15
HUP0202429A3 (en) 2004-04-28
AU781840B2 (en) 2005-06-16
EE200200104A (et) 2003-04-15
KR20080066095A (ko) 2008-07-15
HRP20020267A2 (en) 2004-04-30
SI20852A (sl) 2002-10-31
NO20020999D0 (no) 2002-02-28
WO2001015679A3 (en) 2001-11-22
ES2295050T3 (es) 2008-04-16
CO5200772A1 (es) 2002-09-27
SK287192B6 (sk) 2010-02-08
PL198790B1 (pl) 2008-07-31
BR0014161A (pt) 2002-05-21
EA200200282A1 (ru) 2002-10-31
RO122179B1 (ro) 2009-02-27

Similar Documents

Publication Publication Date Title
NO20020912D0 (no) Bicykliske androgen- og progesteronreseptorer- modulatorforbindelser og fremgangsmåter
NO20014379L (no) Anvendelse av Xenon for behandling av Neurointoksikasjoner
DE60023982D1 (de) System zur Behandlung von benigner Prostatahyperplasie
NO20013380L (no) 2-aminobenzoksazinonderivater for behandling av fedme
NO20024478L (no) Hormonerstatningsterapi ved anvendelse av kombinasjon av konjugerte östrogener og medroksyprogesteronacetat
ATE293971T1 (de) Pharmazeutische kombinationen enthaltend tegaserod und omeprazole und ihre verwendung zur behandlung gastrointestinaler krankheiten
NO20022925D0 (no) EP4 reseptor selektive agonister for behandling av osteoporose
ATE269303T1 (de) Arylpiperazinyl-cyclohexyl indolderivate zur behandlung von depressionen
DE69940131D1 (de) Mittel zur Behandlung von Erkrankungen der Speiseröhre
NO20022974L (no) Anvendelse av biologisk aktive vitamin D-forbindelser for forhindring og behandling av inflammatorisk tarmsykdom
NO20013381D0 (no) 2-oksybenzoksazinonderivater for behandling av fedme
HUP0202049A3 (en) Indole derivatives and their use for the treatment of osteoporosis amongst other applications
NO20005885L (no) Kombinasjonsterapi for behandling av refraktær depresjon
NO20020999D0 (no) Mesoprogestiner (progesteronreseptormodulatorer) for behandling og forhindring av godartete hormonavhengigegynekologiske sykdommer
NO20011537D0 (no) Kjemokinreseptorpeptidvaksiner for behandling og forebygging av diabetes
NO20003229L (no) Kombinasjon av benzosykloheptapyridinforbindelser og antineoplastiske midler for behandling av proliferaktive sykdommer
NO983512D0 (no) Midler for behandling og forhindring av AIDS
NO20014049D0 (no) Kontrollert frigjorings-formulering for behandling av COPD
NO971449D0 (no) Nye hormonelle medikamenter og anvendelse derav for korrigering av östrogen-mangel
NO20013651D0 (no) Anvendelse av fosfororganiske forbindelser for profylaktisk og terapeutisk behandling av infeksjoner
NO20023841D0 (no) Anvendelse av glukokortikoidreseptorantagonister for forebygging og behandling av sykdommer av reproduksjonssystemethos menn
DE60032655D1 (de) Einrichtung zur Chirurgie der Hornhaut
NO20022142D0 (no) Anvendelse av dopamin-D3 reseptor agonister for behandling av saltavhengig hypertensjon
GB9926985D0 (en) Use of substituted (quinolin-2-yl-methoxy)phenyl-acyl-sulphonamides and-cyanamides for the treatment of diseases
NO995314D0 (no) For og anvendelse av slikt for

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application
FC2A Withdrawal, rejection or dismissal of laid open patent application